🇺🇸
United States · US · US:70954-151_1aa670cb-8d65-413a-9bdd-680cafd9b5c4
Naproxen Oral Suspension
Orange BookUNIISPLATC G02CC02
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerANI Pharmaceuticals, Inc.
CountryUS (United States)
ATC codeG02CC02
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc117095415110500 mL in 1 BOTTLE (70954-151-10)
Annotations
UNII (FDA Substance ID)
57Y76R9ATQ
NAPROXEN
RxCUI 7258
Orange Book
A211910
AB
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "57Y76R9ATQ",
"rxcui": "7258",
"inchikey": "CMWTZPSULFXXJA-VIFPVBQESA-N",
"display_name": "NAPROXEN",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"c5146d73-2f34-4dfe-ac29-97071279dc4d": {
"match": "brand_token",
"title": "NAPROXEN SODIUM TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]",
"spl_version": "10",
"published_date": "2026-05-28"
}
},
"productid": "70954-151_1aa670cb-8d65-413a-9bdd-680cafd9b5c4",
"productndc": "70954-151",
"dosage_form": "SUSPENSION",
"orange_book": {
"appl_no": "211910",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "25MG/ML",
"product_no": "001",
"approval_date": "Mar 10, 2021"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "NAPROXEN",
"proprietary_name": "Naproxen Oral Suspension",
"active_ingred_unit": "mg/5mL",
"application_number": "ANDA211910",
"marketing_category": "ANDA",
"nonproprietary_name": "Naproxen oral",
"start_marketing_date": "20210312",
"active_numerator_strength": "125"
}Related drugs
Other records sharing ATC code G02CC02.
Access this data programmatically
Query Naproxen Oral Suspension and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.